News from CNBC Business
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Shares
Crypto Assets
Stock
Cryptocurrency
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Stablecoin
Blockchain
Etf
Sec
Eth
Bse
Ipo
Index
Solana
Trade
Earnings
Inflation
Revenue
Coinbase
Interest Rates
China
Token
Wall Street
Sensex
Nasdaq
Gold
Federal Reserve
Traders
Nse
Treasury
Economy
Bse Sensex
Usd
Trade War
Profit
Tesla
Nifty
Sp 500
Gainers
Mempool
Sport
Defense Sector
Tariff Cut
Uki
Bullish Indicators
Transfer Volume
Debt Fund
Joint Investment
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jun 09, 2025
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →